Comparing the current results to its competitors, Cutera Inc reported Revenue decrease in the 3 quarter 2024 year on year by -31.52 %, despite the revenue increase by the most of its competitors of 6.5 %, recorded in the same quarter.
Cutera Inc 's Comment on Competition and Industry Peers
The Company operates in a competitive industry, with its products competing against conventional non-energy-based treatments such as electrolysis, Botox, collagen injections, chemical peels, microdermabrasion, and sclerotherapy. It also competes with laser and other energy-based products from public companies including Abbvie (which acquired Allergan and its division Zeltiq), Bausch Health (formerly Valeant Pharmaceuticals), InMode, and Lutronic. Private competitors include Sisram (parent company of Alma Lasers), Candela (formerly Syneron Candela, acquired in 2017 by an affiliate of private equity funds advised by Apax Partners), Sciton, BTL Industries, Accure Acne, and others. In late 2019, Clayton, Dubilier & Rice acquired Cynosure, LLC, a provider of medical aesthetics systems and technology. The Company also faces competition from North America-based distribution companies such as Cartessa Aesthetics, Reveal Lasers, and Aesthetic Management Partners (AMP). Competition in the industry involves extensive research and development and innovative technology. Despite patents and intellectual property protections, barriers to entry are limited, with many public and private companies developing competing devices. Some competitors have greater resources or focus on sub-markets where the Company does not operate. The Company must demonstrate that its products are attractive alternatives to other devices and treatments to compete effectively.
Venus Concept Inc's business model focuses on offering innovative and effective medical aesthetic devices and technology solutions to healthcare professionals.
Lensar Inc is a medical technology company that operates through a business model focused on the development and commercialization of advanced laser systems for ophthalmic procedures. They aim to provide innovative solutions to healthcare professionals in order to enhance precision, safety, and efficiency in eye surgeries.
Iridex Corp's business model revolves around providing advanced medical devices and solutions for the treatment of eye conditions, primarily focused on ophthalmology.
Inmode Ltd is a medical technology company that specializes in developing and commercializing minimally invasive aesthetic and medical solutions. They primarily operate on a direct-to-consumer model, selling their devices to physicians, medical spas, and clinics. In addition to device sales, they generate recurring revenue through consumable product sales and service contracts for their devices.
Sources:
Cutera Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cutera Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
